Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Menopause. 2019 Apr;26(4):373–382. doi: 10.1097/GME.0000000000001249

Table 2.

Outcome and theory-based variables by group at the pre-test.

Outcome variables
(Mean±SD)
Range Control
(N=42)
Intervention
(N=49)
Total
(N=91)
p
Symptom Distress
 Physical symptomsa 0.8–2.4 1.40±0.38 1.42±0.50 1.41±0.45 .82
 Psycho logical symptomsb 0.8–2.9 1.67±0.50 1.72±0.70 1.70±0.61 .66
 Psychosomatic symptomsc 0.8–3.5 1.67±0.63 1.89±0.84 1.75±0.75 .35
 Total 0.8–2.6 1.58±0.39 1.65±0.58 1.62±0.50 .66
Symptom Frequency
 Psychological symptomsd
 (log transformed)
0.9–3.6 1.93±0.67 1.84±0.73 1.89±0.70 .57
Theory-based variables
 Attitudes 1.2–5.9 3.49 (2.03) 4.06 (1.89) 3.80 (1.96) .17
 Social influences 1.1–6.8 5.72 (1.45) 5.61 (1.28) 5.67 (1.36) .71
 Perceived barriers 1.0–3.9 3.12 (0.55) 2.98 (0.61) 3.05 (0.59) .27
 Self-efficacy 1.1–8.8 5.96 (1.56) 6.16 (1.77) 6.06 (1.67) .55

SD = standard deviation/ All categories of symptoms were measured using the MSAS-SF.

a

Physical symptoms included ‘nausea,’ ‘vomiting,’ ‘shortness of breath,’ ‘sweats,’ ‘feeling bloated,’ ‘problems with urination,’ ‘diarrhea,’ ‘weight loss,’ ‘itching,’ ‘changes in skin,’ ‘constipation,’ ‘swelling of arms or legs,’ ‘numbness/tingling in hands/feet,’ ‘lack of appetite,’ and ‘pain.’

b

Psychological symptoms included ‘difficulty concentrating’ and ‘problems with sexual interest or activity.’

c

Psychosomatic symptoms included ‘difficulty sleeping’ and ‘dizziness.’

d

Psychological symptoms included ‘feeling sad,’ ‘worrying,’ ‘feeling irritable,’ and ‘feeling nervous.’